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PRELIMINARY AND SHORT REPORT
EFFECT OP CANDICIDIN IN INTERTRIGINOUS AND PARONYCHIAL
MONILIASIS
A PRELIMINARY RRrowr*
ANDREW G. FRANKS, M.D., CLAIRE L. TASCHDJIAN, B.S., AND GRACE A. THORPE, B.A.
Candicidin, an antibiotic with marked activity again8t yeasts and yeast-like organisms,
was recently isolated from a soil actinomycete similar to ,Streptomyces griseus (1). The sub-
stance showed promising results against Candida albicans in vitro and in experimental
moniliasis. In its present state of purification it is still too toxic for internal administration,
but no adverse effects were noted when it was applied to the human oral mucosa for periods
of 48 hours or more (2).
A limited amount of the antibiotic in two forms, designated as Candicidin A and Can-
dicidin B, respectively, was put at the disposal of the Mycology Section of the New York
Skin and Cancer Unit for a clinical trial. The results of this trial are herewith presented.
PROCEDURE
Candicidin A, being water soluble, was used in a 1% aqueous solution. Candicidin B,
insoluble in water, was used in polyethylene glycol in the same concentration.
Where feasible, the patients were instructed to apply Candicidin in one infected area, and
the solvent in a contralateral infected area as a control.
Seven patients were treated. Four of these had intertriginous moniliasis, while three
suffered from paronychia. In all cases the clinical diagnosis of moniliasis was confirmed by
direct smears and by cultures on Sabouraud's and rice infusion agar (3).
Our findings are summarized in Table I.
DISCUSSION
These preliminary data indicate that Candicidin B in polyethylene glycol is quite effec-
tive in freshly contracted intertriginous moniliasis. The three patients suffering from fresh
infections remarked on the almost immediate relief from pruritus experienced after the first
few applications. Two of these patients had been treated with gentian violet prior to using
Candicidin B without obtaining relief. These patients commented on the cleanliness of
the Candicidin treatment in addition to its efficacy.
The results obtained with Candicidin A in paronychia and intertrigo are not encouraging.
On the basis of our findings, it appears that Candicidin B in polyethylene glycol is ther-
apeutically effective for iutertriginous moniliasis. Its efficacy in paronychia and chronic
intertrigo was not apparent in our material.
SUMMARY
One per cent Candicidin A in aqueous solution and Candicidin B in polyethylene glycol
were used in four cases of intertriginous and three cases of paronychial moniliasis. Three
patients with freshly contracted monilial intertrigo cleared up within ten days' treatment
with Candicidin B. The fourth, a chronic case, responded after seven weeks to Candicidin
A, with relapse after one month. The three cases of paronychia failed to show appreciable
improvement after three months' treatment with Candicidin A.
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TABLE I
Effect of 1% Candicidin in aqueous solution (Candicidin A) and in polyethylene glycot
(Candicidin B) applied twice daily
CASZ
NO. SITZ DUZATXON CAEDICIDIN cLZA3ED MTZR 1ZILAUS
1 Vulva, 1 week B 7 days No recurrence after 1
inter- year
gluteal
fold
2 Inguinal 1 week B 10 days No recurrence after 1
regions, year
lower ab-
domen
3 Groin 1 week B 8 days Pt. developed furuncu-
losis in groin after
Candicidin was stop-
ped. No recurrence of
moniliasis after terra-
mycin
4 Submam- 2 years A to right 42 days, all Recurrence in submam-
mary and side; con- areas mary regions 4 weeks
inguinal trol A to after treatment was
regions left side stopped
5 Nail beds 1 year A; control A No improve-
ment after
3 months
6 Nail beds 2 months A; control A No improve- Patient did not return
ment after
5 weeks
7 Nail beds 9 weeks A; control A Slight im-
provement
on test area
after 3
months
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